Comparative Outcomes of Microwave Ablation Versus Surgery for Papillary Thyroid Microcarcinoma

21 October 2025 : Clinical Research

Gang Hu^{AE 1}, LiHua Xu^{B 1}, WanJu Wang^{C 1*}, Rui Zhou^{BF 2}

DOI: 10.12659/MSM.948460

Med Sci Monit 2025; 31:e948460

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 1 Comparison of baseline data of microwave ablation group and surgery group.

	MWA	Surgery	t/Z/χ2	P
Age (y)	38.2±3.83	39.7±3.71	1.542	0.128
Maximal tumor diameter (mm)	7.18±0.84	7.46±0.99	1.173	0.245
Sex (Male)	11 (36.7%)	13 (43.3%)	0.278	0.598
FT3 (pmol/L)	5.16 (4.95, 5.22)	5.12 (4.97, 5.18)	0.747	0.455
FT4 (pmol/L)	13.93 (12.16, 14.39)	13.85 (12.51, 14.62)	0.849	0.399
TSH (μIU/mL)	2.13 (2.00, 2.64)	2.18 (2.06, 2.31)	0.155	0.877
Follow-up date (months)	27.63±5.46	27.57±6.75	0.042	0.967
FT3 – free T3; FT4 – free T4; TSH – thyroid stimulating hormone; MWA – microwave ablation.

Back to the Article